Deal Tracker · Countries
Saudi Arabia pharma deals
69 pharma deals involving Saudi Arabia — companies based there or deals covering the market — tracked by EPT: licensing, distribution & localization. Most active: Jamjoom Pharma, SPIMACO, ADCAN Pharma & Avalon Pharma. Latest: Emmaus Life Sciences → Al Wataniya Aldawliya (Distribution, 12 Nov 2026).
- EPT has tracked 69 Saudi Arabia pharma deals (2014–2026), 48 of them announced in 2026.
- The most common structures are licensing (35%), distribution (20%) & localization (14%).
- Values were disclosed for 6 of 69 deals, totalling $521.7m; the largest is DKSH → NewBridge Pharmaceuticals ($390m, 19 Oct 2026).
- The most active companies: Jamjoom Pharma (7), SPIMACO (7), ADCAN Pharma (6) & Avalon Pharma (5).
- Emmaus Life Sciences → Al Wataniya AldawliyaDistribution · MENA · Undisclosed · 12 Nov 2026
- Hikma Ventures → Rem3dy HealthEquity / Investment · MENA · Undisclosed · 11 Nov 2026
- Saudi Industrial Development Fund → Avalon PharmaEquity / Investment · GCC · $16m · 9 Nov 2026
- Oman Investment Authority → Oryx IsotopesJoint venture · GCC · $17m · 8 Nov 2026
- Alkem Laboratories → Vitals BiotechJoint venture · GCC · $2m · 8 Nov 2026
- Bukwang Pharmaceutical → NASAQLicensing · GCC · $2.7m · 4 Nov 2026
- Geropharm → Al Quds Medical ProductsTechnology transfer / Localization · MENA · Undisclosed · 3 Nov 2026
- Rem3dy Health → Hikma PharmaceuticalsDistribution · GCC · Undisclosed · 29 Oct 2026
- Eva Pharma → United PharmaciesDistribution · GCC · Undisclosed · 26 Oct 2026
- QOL Medical → Qurqas Pharmaceutical WarehouseDistribution · MENA · Undisclosed · 22 Oct 2026
- Mubadala Bio → Jamjoom PharmaDistribution · GCC · 21 Oct 2026
- DKSH → NewBridge PharmaceuticalsM&A / Acquisition · MENA · $390m · 19 Oct 2026
- Inventia Healthcare → ADCAN PharmaLicensing · GCC · 14 Oct 2026
- Sandoz → Tabuk PharmaceuticalsTechnology transfer / Localization · GCC · Undisclosed · 13 Oct 2026
- Lotus Pharmaceutical → ADCAN PharmaLicensing · MENA · 9 Oct 2026
- Genepharm → ADCAN PharmaLicensing · GCC · 9 Oct 2026
- Alvion Pharmaceuticals → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- OneSource Specialty Pharma → Avalon PharmaLicensing · MENA · Undisclosed · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 7 Oct 2026
- Aurisco Pharmaceutical → Avalon PharmaPartnership / Collaboration · MENA · Undisclosed · 6 Oct 2026
- Cordex Biologics → Farma MondoDistribution · GCC · 25 Sept 2026
- Local Content and Government Procurement Authority → SPIMACOTechnology transfer / Localization · GCC · Undisclosed · 16 Sept 2026
- Shilpa Biologicals → SPIMACOLicensing · MENA · Undisclosed · 15 Sept 2026
- Nordic Pharma → Jamjoom PharmaLicensing · MENA · Undisclosed · 14 Sept 2026
- Pharmacare Premium → Arabian OasisPartnership / Collaboration · GCC · Undisclosed · 3 Sept 2026
- AstraZeneca → KAIMRCPartnership / Collaboration · GCC · 29 Aug 2026
- Rhei Life → Atheer PharmaDistribution · GCC · Undisclosed · 21 Aug 2026
- Cosmos Health → Innova HealthcareDistribution · GCC · Undisclosed · 20 Aug 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 16 Aug 2026
- Alfasigma → Nordic PharmaM&A / Acquisition · Global ex-US · See terms · 9 Aug 2026
- SPIMACO → Cigalah Drug StoreDistribution · GCC · Undisclosed · 30 Jul 2026
- SPIMACO → Cigalah Gulf MedicalDistribution · GCC · Undisclosed · 30 Jul 2026
- Mabwell Bioscience → SaudiVaxLicensing · GCC · Undisclosed · 29 Jul 2026
- Idorsia → Jamjoom PharmaLicensing · MENA · See terms · 27 Jul 2026
- Lifera → Jamjoom PharmaJoint venture · GCC · See terms · 23 Jul 2026
- Itqan Pharmaceuticals → Address HealthcareDistribution · GCC · Undisclosed · 21 Jul 2026
- Northwest Biotherapeutics → SPIMACOPartnership / Collaboration · MENA · Undisclosed · 12 Jul 2026
- Bausch Health → AUG PharmaM&A / Acquisition · GCC · Undisclosed · 12 Jul 2026
- Adalvo → Doctors PharmaceuticalLicensing · MENA · Undisclosed · 1 Jul 2026
- Daewoong Pharmaceutical → Arcera Life SciencesLicensing · MENA · $94m · 29 Jun 2026
- Genetix Biotherapeutics → SPIMACOLicensing · MENA · Undisclosed · 23 Jun 2026
- CEL-SCI → Saudi AmaroxDistribution · MENA · Undisclosed · 22 Jun 2026
- Glaxo Saudi Arabia → AJA PharmaPartnership / Collaboration · GCC · Undisclosed · 15 Jun 2026
- Pfizer → Jamjoom PharmaM&A / Acquisition · MENA · Undisclosed · 27 Apr 2026
- Jerusalem Pharmaceuticals → Saudi investorsJoint venture · GCC · Undisclosed · 15 Apr 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 3 Feb 2026
- Chemo & Olpha → CCL PharmaceuticalsSupply / Manufacturing · GCC · Undisclosed · 28 Jan 2026
- Algorithm → Batterjee PharmaTechnology transfer / Localization · GCC · Undisclosed · 30 Nov 2025
- Bayer → Alfa PharmaTechnology transfer / Localization · GCC · Undisclosed · 27 Nov 2025
- Local Content and Government Procurement Authority → AJA PharmaTechnology transfer / Localization · GCC · See terms · 22 Nov 2025
- CSL Seqirus → Vaccine IndustrialPartnership / Collaboration · GCC · 30 Oct 2025
- BioRay Pharmaceutical → Tabuk PharmaceuticalsLicensing · MENA · Undisclosed · 29 Oct 2025
- Local Content and Government Procurement Authority → Sudair PharmaTechnology transfer / Localization · GCC · Undisclosed · 28 Oct 2025
- Local Content and Government Procurement Authority → Tabuk PharmaceuticalsTechnology transfer / Localization · GCC · Undisclosed · 28 Oct 2025
- Local Content and Government Procurement Authority → Boston OncologyTechnology transfer / Localization · GCC · Undisclosed · 28 Oct 2025
- Lifera → King Faisal Specialist Hospital & Research CentrePartnership / Collaboration · MENA · Undisclosed · 28 Oct 2025
- Bio-Thera Solutions → Jamjoom PharmaLicensing · MENA · Undisclosed · 15 Sept 2025
- BioGeneric Pharma → GWMTechnology transfer / Localization · GCC · Undisclosed · 30 Jul 2025
- Althera Laboratories → Jamjoom PharmaLicensing · MENA · Undisclosed · 30 Jul 2025
- Kashiv BioSciences → MS PharmaLicensing · MENA · Undisclosed · 8 May 2025
- Novo Nordisk → LiferaSupply / Manufacturing · GCC · 24 Apr 2025
- Apex Pharma → CIGALAH HealthcareDistribution · GCC · Undisclosed · 17 Apr 2025
- EQL Pharma → PharmalinkDistribution · GCC · See terms · 11 Mar 2025
- Bio-Thera Solutions → Tabuk PharmaceuticalsLicensing · GCC · Undisclosed · 24 Dec 2024
- Shanghai Henlius Biotech → SaudiVaxJoint venture · MENA · Undisclosed · 8 Nov 2024
- Biocon → Tabuk PharmaceuticalsLicensing · MENA · Undisclosed · 9 Feb 2024
- Huadong Medicine → JulpharPartnership / Collaboration · MENA · Undisclosed · 25 Jun 2022
- Jiangsu Recbio Technology → SPIMACOLicensing · MENA · Undisclosed · 23 Jan 2014
Most active companies
Jamjoom Pharma (7) · SPIMACO (7) · ADCAN Pharma (6) · Avalon Pharma (5) · Local Content and Government Procurement Authority (5) · Tabuk Pharmaceuticals (5)
Largest disclosed deals
- DKSH → NewBridge Pharmaceuticals · $390m · M&A / Acquisition · 19 Oct 2026
- Daewoong Pharmaceutical → Arcera Life Sciences · $94m · Licensing · 29 Jun 2026
- Oman Investment Authority → Oryx Isotopes · $17m · Joint venture · 8 Nov 2026
Questions
- How many Saudi Arabia pharma deals has EPT tracked?
- 69 as of 12 Nov 2026, covering 2014–2026; 48 were announced in 2026. The most recent is Emmaus Life Sciences → Al Wataniya Aldawliya (Distribution, 12 Nov 2026).
- What types of Saudi Arabia pharma deals are most common?
- Licensing: 24 (35%); Distribution: 14 (20%); Technology transfer / Localization: 10 (14%); Partnership / Collaboration: 8 (12%).
- Which companies are most active in Saudi Arabia pharma deals?
- Jamjoom Pharma (7 deals), SPIMACO (7 deals), ADCAN Pharma (6 deals), Avalon Pharma (5 deals), Local Content and Government Procurement Authority (5 deals), Tabuk Pharmaceuticals (5 deals).
- What is the largest disclosed Saudi Arabia pharma deal?
- DKSH → NewBridge Pharmaceuticals: $390m (M&A / Acquisition, 19 Oct 2026); Daewoong Pharmaceutical → Arcera Life Sciences: $94m (Licensing, 29 Jun 2026); Oman Investment Authority → Oryx Isotopes: $17m (Joint venture, 8 Nov 2026). Values are as announced by the parties.
Browse deals
By region
GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)
By country
UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)
By deal type
Licensing (56) · Distribution (41) · Technology transfer / Localization (39) · Partnership / Collaboration (35) · M&A / Acquisition (21) · Equity / Investment (18) · Joint venture (11) · Supply / Manufacturing (10)
Popular searches
MENA pharma licensing deals (25) · Saudi Arabia pharma licensing deals (24) · GCC pharma distribution deals (21) · GCC pharma partnerships (19) · China pharma licensing deals (17) · UAE pharma distribution deals (17) · GCC pharma localization & tech-transfer deals (15) · Saudi Arabia pharma distribution deals (14) · UAE pharma partnerships (13) · UAE pharma licensing deals (12) · Global (LMICs) pharma licensing deals (11) · India pharma licensing deals (11) · GCC pharma licensing deals (10) · MENA pharma partnerships (10) · Saudi Arabia pharma localization & tech-transfer deals (10) · MENA pharma localization & tech-transfer deals (9) · United States pharma licensing deals (9) · Egypt pharma localization & tech-transfer deals (8) · Saudi Arabia pharma partnerships (8) · CIS & Central Asia pharma localization & tech-transfer deals (7) · Kazakhstan pharma localization & tech-transfer deals (7) · MENA pharma distribution deals (7) · MENA pharma M&A deals (7) · United States pharma distribution deals (7)
By company
ADCAN Pharma (13) · Mubadala Bio (8) · Jamjoom Pharma (7) · SPIMACO (7) · Arcera Life Sciences (6) · Hikma Pharmaceuticals (6) · Bio-Thera Solutions (6) · Avalon Pharma (5) · Tabuk Pharmaceuticals (5) · Local Content and Government Procurement Authority (5) · Kazakhstan Ministry of Health (5) · Eva Pharma (4) · Sandoz (4) · Department of Health – Abu Dhabi (4) · Biocon (4) · Groupe Saidal (4) · Gilead Sciences (3) · Dr. Reddy's Laboratories (3) · Emirates Drug Establishment (3) · Novo Nordisk (3) · Khazaen Economic City (3) · Galenicum (3) · Roche (3) · Laprophan (3) · Sanofi (3) · Gen İlaç (3) · Taiba Healthcare (3) · Dar Al Dawa (3) · Lifera (3) · Celltrion (2) · Viatris (2) · Rem3dy Health (2) · AMA Medical Manufacturing (2) · Afreximbank (2) · M42 (2) · Abbott (2) · DKSH (2) · Adalvo (2) · Rameda (2) · Menarini (2) · Korea United Pharm (2) · Samsung Bioepis (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · Duopharma Biotech (2) · JCR Pharmaceuticals (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · Accord Healthcare (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · UNIMED Laboratories (2) · Minapharm (2) · SaudiVax (2) · Faes Farma (2) · AJA Pharma (2) · VACSERA (2) · Bayer (2) · Shanghai Henlius Biotech (2) · Julphar (2)
By therapeutic area
Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)